Efficacy of topical isotretinoin 0.05% gel in acne vulgaris: results of a multicenter, double-blind investigation. 1987

D K Chalker, and J L Lesher, and J G Smith, and H C Klauda, and P E Pochi, and W S Jacoby, and D M Yonkosky, and J J Voorhees, and C N Ellis, and S Matsuda-John

Two hundred sixty-eight patients with mild to moderate acne vulgaris completed a multicenter, double-blind, controlled study comparing isotretinoin 0.05% gel with its vehicle. Patients were treated twice daily for up to 14 weeks. Efficacy was measured by counting facial inflammatory and noninflammatory lesions and by grading acne severity initially and at 2- to 3-week intervals throughout the study. The isotretinoin 0.05% gel proved to be statistically more effective than vehicle in reducing inflammatory lesions after 5 weeks and in reducing noninflammatory lesions and acne severity grade after 8 weeks. Except for two patients who dropped out because of irritation, isotretinoin 0.05% gel was well tolerated.

UI MeSH Term Description Entries
D008297 Male Males
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D005260 Female Females
D005782 Gels Colloids with a solid continuous phase and liquid as the dispersed phase; gels may be unstable when, due to temperature or other cause, the solid phase liquefies; the resulting colloid is called a sol.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000152 Acne Vulgaris A chronic disorder of the pilosebaceous apparatus associated with an increase in sebum secretion. It is characterized by open comedones (blackheads), closed comedones (whiteheads), and pustular nodules. The cause is unknown, but heredity and age are predisposing factors. Acne
D000287 Administration, Topical The application of drug preparations to the surfaces of the body, especially the skin (ADMINISTRATION, CUTANEOUS) or mucous membranes. This method of treatment is used to avoid systemic side effects when high doses are required at a localized area or as an alternative systemic administration route, to avoid hepatic processing for example. Drug Administration, Topical,Administration, Topical Drug,Topical Administration,Topical Drug Administration,Administrations, Topical,Administrations, Topical Drug,Drug Administrations, Topical,Topical Administrations,Topical Drug Administrations
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

D K Chalker, and J L Lesher, and J G Smith, and H C Klauda, and P E Pochi, and W S Jacoby, and D M Yonkosky, and J J Voorhees, and C N Ellis, and S Matsuda-John
May 1992, Clinical and experimental dermatology,
D K Chalker, and J L Lesher, and J G Smith, and H C Klauda, and P E Pochi, and W S Jacoby, and D M Yonkosky, and J J Voorhees, and C N Ellis, and S Matsuda-John
September 2002, The British journal of dermatology,
D K Chalker, and J L Lesher, and J G Smith, and H C Klauda, and P E Pochi, and W S Jacoby, and D M Yonkosky, and J J Voorhees, and C N Ellis, and S Matsuda-John
January 2014, Advanced biomedical research,
D K Chalker, and J L Lesher, and J G Smith, and H C Klauda, and P E Pochi, and W S Jacoby, and D M Yonkosky, and J J Voorhees, and C N Ellis, and S Matsuda-John
March 1991, Journal of the American Academy of Dermatology,
D K Chalker, and J L Lesher, and J G Smith, and H C Klauda, and P E Pochi, and W S Jacoby, and D M Yonkosky, and J J Voorhees, and C N Ellis, and S Matsuda-John
January 1999, Dermatology (Basel, Switzerland),
D K Chalker, and J L Lesher, and J G Smith, and H C Klauda, and P E Pochi, and W S Jacoby, and D M Yonkosky, and J J Voorhees, and C N Ellis, and S Matsuda-John
January 2003, Indian journal of dermatology, venereology and leprology,
D K Chalker, and J L Lesher, and J G Smith, and H C Klauda, and P E Pochi, and W S Jacoby, and D M Yonkosky, and J J Voorhees, and C N Ellis, and S Matsuda-John
January 2007, Indian journal of dermatology, venereology and leprology,
D K Chalker, and J L Lesher, and J G Smith, and H C Klauda, and P E Pochi, and W S Jacoby, and D M Yonkosky, and J J Voorhees, and C N Ellis, and S Matsuda-John
May 2009, Journal of the European Academy of Dermatology and Venereology : JEADV,
D K Chalker, and J L Lesher, and J G Smith, and H C Klauda, and P E Pochi, and W S Jacoby, and D M Yonkosky, and J J Voorhees, and C N Ellis, and S Matsuda-John
May 1981, International journal of dermatology,
D K Chalker, and J L Lesher, and J G Smith, and H C Klauda, and P E Pochi, and W S Jacoby, and D M Yonkosky, and J J Voorhees, and C N Ellis, and S Matsuda-John
January 2010, Indian journal of dermatology, venereology and leprology,
Copied contents to your clipboard!